Hacarus Inc. announced that it has received ¥170,000,000 in an equity round of funding on July 12, 2018. The transaction involved participation from MEDI FUTURES Co. Ltd., Ohara Pharmaceutical Co., Ltd., Essential Pharma Limited, Miyako Capital, Capital Medica Ventures Co., Ltd. The company issued the shares by a way of third party allotment.